Cite

    C P Kotanidis et al.. “A human arterial transcriptomic signature predicts major adverse cardiac events and identifies novel, redox-related therapeutic targets within the vascular wall.” European heart journal, vol. 42, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100144496900.0x00004d